- Home
- DFLI vs GRCE Comparison
DFLI vs GRCE Comparison
Compare DFLI & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFLI
- GRCE
- Stock Information
- Founded
- DFLI 2020
- GRCE 2002
- Country
- DFLI United States
- GRCE United States
- Employees
- DFLI N/A
- GRCE N/A
- Industry
- DFLI Electronic Components
- GRCE
- Sector
- DFLI Technology
- GRCE
- Exchange
- DFLI Nasdaq
- GRCE NYSE
- Market Cap
- DFLI 36.1M
- GRCE 30.9M
- IPO Year
- DFLI N/A
- GRCE N/A
- Fundamental
- Price
- DFLI $0.49
- GRCE $3.15
- Analyst Decision
- DFLI Strong Buy
- GRCE
- Analyst Count
- DFLI 5
- GRCE 0
- Target Price
- DFLI $1.74
- GRCE N/A
- AVG Volume (30 Days)
- DFLI 245.8K
- GRCE 44.3K
- Earning Date
- DFLI 11-14-2024
- GRCE 11-13-2024
- Dividend Yield
- DFLI N/A
- GRCE N/A
- EPS Growth
- DFLI N/A
- GRCE N/A
- EPS
- DFLI N/A
- GRCE N/A
- Revenue
- DFLI $48,871,000.00
- GRCE N/A
- Revenue This Year
- DFLI N/A
- GRCE N/A
- Revenue Next Year
- DFLI $64.82
- GRCE N/A
- P/E Ratio
- DFLI N/A
- GRCE N/A
- Revenue Growth
- DFLI N/A
- GRCE N/A
- 52 Week Low
- DFLI $0.43
- GRCE $1.98
- 52 Week High
- DFLI $1.46
- GRCE $3.60
- Technical
- Relative Strength Index (RSI)
- DFLI 38.35
- GRCE N/A
- Support Level
- DFLI $0.49
- GRCE N/A
- Resistance Level
- DFLI $0.54
- GRCE N/A
- Average True Range (ATR)
- DFLI 0.03
- GRCE 0.00
- MACD
- DFLI -0.00
- GRCE 0.00
- Stochastic Oscillator
- DFLI 9.04
- GRCE 0.00
About DFLI Dragonfly Energy Holdings Corp. (NV)
Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a highly cost-effective storage solution.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.